Identification of the Underlying Androgen Receptor Defect in the Dallas Reifenstein Family

Overview

Journal J Endocr Soc

Specialty Endocrinology

Date 2017 Dec 22

PMID 29264534

Authors

Zahid Ahmad

Chao Xing

Kamaldeep Panach

Ralf Kittler

Michael J McPhaul

Jean D Wilson

Affiliations

Soon will be listed here.

Abstract

Context: The Dallas Reifenstein family - first described in 1965 - includes 14 known members with partial androgen insensitivity syndrome (PAIS). However, the underlying molecular defect was never identified.

Objective: To identify the underlying genetic defect for PAIS in the Dallas Reifenstein family.

Design: DNA was purified from scrotal skin fibroblasts, and whole exome sequencing was then performed in four affected men in the family. Additional family members - both affected and unaffected - were subsequently recruited to confirm segregation of the candidate mutations with the PAIS phenotype.

Patients: The affected men have PAIS with infertility associated with azoospermia, hypospadias, and gynecomastia.

Results: All four men harbored an intronic variant NC_000023.10:g.66788676A>C between exon 1 and exon 2 of the androgen receptor ( canonical transcript NM_000044 (complementary DNA position NM_000044: c.1616+22072A>C) predicted to cause an alternatively spliced transcript. Reverse transcription (RT) polymerase chain (PCR) experiments detected the predicted PCR product of the alternatively spliced transcript, and the mutation segregated with the PAIS phenotype in this family. The transcript includes the insertion of 185 nucleotides with a premature stop codon at chrX:66863131-66863133, likely resulting in a reduction in AR protein expression due to nonsense-mediated decay.

Conclusions: An intronic mutation was identified in the Dallas Reifenstein family. The findings suggest that in cases of PAIS without identifiable mutations in coding regions, intronic mutations should be considered.

References

Grino P, GRIFFIN J, Wilson J . Androgen resistance due to decreased amounts of androgen receptor: a reinvestigation. J Steroid Biochem. 1990; 35(6):647-54. DOI: 10.1016/0022-4731(90)90304-b. View

Gottlieb B, Beitel L, Nadarajah A, Paliouras M, Trifiro M . The androgen receptor gene mutations database: 2012 update. Hum Mutat. 2012; 33(5):887-94. DOI: 10.1002/humu.22046. View

Hughes I, Davies J, Bunch T, Pasterski V, Mastroyannopoulou K, MacDougall J . Androgen insensitivity syndrome. Lancet. 2012; 380(9851):1419-28. DOI: 10.1016/S0140-6736(12)60071-3. View

Infante J, Alvelos M, Bastos M, Carrilho F, Lemos M . Complete androgen insensitivity syndrome caused by a novel splice donor site mutation and activation of a cryptic splice donor site in the androgen receptor gene. J Steroid Biochem Mol Biol. 2015; 155(Pt A):63-6. DOI: 10.1016/j.jsbmb.2015.09.042. View

Bruggenwirth H, Boehmer A, Ramnarain S, Satijn D, Trapman J, Grootegoed J . Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation. Am J Hum Genet. 1997; 61(5):1067-77. PMC: 1716041. DOI: 10.1086/301605. View

Lucas-Herald A, Bertelloni S, Juul A, Bryce J, Jiang J, Rodie M . The Long-Term Outcome of Boys With Partial Androgen Insensitivity Syndrome and a Mutation in the Androgen Receptor Gene. J Clin Endocrinol Metab. 2016; 101(11):3959-3967. PMC: 5095251. DOI: 10.1210/jc.2016-1372. View

Mongan N, Tadokoro-Cuccaro R, Bunch T, Hughes I . Androgen insensitivity syndrome. Best Pract Res Clin Endocrinol Metab. 2015; 29(4):569-80. DOI: 10.1016/j.beem.2015.04.005. View

Roca X, Sachidanandam R, Krainer A . Intrinsic differences between authentic and cryptic 5' splice sites. Nucleic Acids Res. 2003; 31(21):6321-33. PMC: 275472. DOI: 10.1093/nar/gkg830. View

Wieacker P, GRIFFIN J, Wienker T, Lopez J, Wilson J, Breckwoldt M . Linkage analysis with RFLPs in families with androgen resistance syndromes: evidence for close linkage between the androgen receptor locus and the DXS1 segment. Hum Genet. 1987; 76(3):248-52. DOI: 10.1007/BF00283617. View

10.

Starokadomskyy P, Gemelli T, Rios J, Xing C, Wang R, Li H . DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis. Nat Immunol. 2016; 17(5):495-504. PMC: 4836962. DOI: 10.1038/ni.3409. View

11.

Baxter R, Arboleda V, Lee H, Barseghyan H, Adam M, Fechner P . Exome sequencing for the diagnosis of 46,XY disorders of sex development. J Clin Endocrinol Metab. 2014; 100(2):E333-44. PMC: 4318895. DOI: 10.1210/jc.2014-2605. View

12.

Ris-Stalpers C, Kuiper G, Faber P, Schweikert H, van Rooij H, Zegers N . Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. Proc Natl Acad Sci U S A. 1990; 87(20):7866-70. PMC: 54851. DOI: 10.1073/pnas.87.20.7866. View

13.

Hughes I, Deeb A . Androgen resistance. Best Pract Res Clin Endocrinol Metab. 2006; 20(4):577-98. DOI: 10.1016/j.beem.2006.11.003. View

14.

Meyer 3rd W, MIGEON B, Migeon C . Locus on human X chromosome for dihydrotestosterone receptor and androgen insensitivity. Proc Natl Acad Sci U S A. 1975; 72(4):1469-72. PMC: 432557. DOI: 10.1073/pnas.72.4.1469. View

15.

Bowen P, Lee C, Migeon C, Kaplan N, WHALLEY P, MCKUSICK V . HEREDITARY MALE PSEUDOHERMAPHRODITISM WITH HYPOGONADISM, HYPOSPADIAS, AND GYNECOMASTIA: REIFENSTEIN'S SYNDROME. Ann Intern Med. 1965; 62:252-70. DOI: 10.7326/0003-4819-62-2-252. View

16.

Lee H, Deignan J, Dorrani N, Strom S, Kantarci S, Quintero-Rivera F . Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014; 312(18):1880-7. PMC: 4278636. DOI: 10.1001/jama.2014.14604. View

17.

Boycott K, Vanstone M, Bulman D, MacKenzie A . Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet. 2013; 14(10):681-91. DOI: 10.1038/nrg3555. View

18.

Islamaj Dogan R, Getoor L, Wilbur W, Mount S . SplicePort--an interactive splice-site analysis tool. Nucleic Acids Res. 2007; 35(Web Server issue):W285-91. PMC: 1933122. DOI: 10.1093/nar/gkm407. View

19.

Hornig N, de Beaufort C, Denzer F, Cools M, Wabitsch M, Ukat M . A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation. PLoS One. 2016; 11(4):e0154158. PMC: 4844194. DOI: 10.1371/journal.pone.0154158. View

20.

Kansakoski J, Jaaskelainen J, Jaaskelainen T, Tommiska J, Saarinen L, Lehtonen R . Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene. Sci Rep. 2016; 6:32819. PMC: 5016895. DOI: 10.1038/srep32819. View